ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
SPDR S&P Telecom ETF

SPDR S&P Telecom ETF (XTL)

109,53
-0,3912
(-0,36%)
Fermé 28 Novembre 10:00PM
109,46
-0,07
(-0,06%)
Après les heures de négociation: 1:59AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
109,53
Prix Achat
-
Prix Vente
-
Volume échangé
4 833
109,0069 Fourchette du Jour 110,60
67,08 Plage de 52 semaines 111,2338
Cap du marché
Clôture Veille
109,9212
Ouverture
110,60
Dernière Transaction
2068
@
109.53
Dernière heure de transaction
Volume financier
US$ 531 037
VWAP
109,8774
Volume moyen (3 m)
14 360
Actions en circulation
775 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2 493,39
Bénéfice par action (BPA)
-0,04
Chiffre d'affairess
671k
Bénéfice net
-34k

À propos de SPDR S&P Telecom ETF

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the telecommunications segment of a U. In seeking to track the performance of the S&P Telecom Select Industry Index (the index), the fund e... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the telecommunications segment of a U. In seeking to track the performance of the S&P Telecom Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the telecommunications segment of the S&P Total Market Index (S&P TMI). Show more

Secteur
Mgmt Invt Offices, Open-end
Industrie
Mgmt Invt Offices, Open-end
Site Web
Siège social
Boston, Massachusetts, USA
Fondé
-
SPDR S&P Telecom ETF est coté dans le secteur Mgmt Invt Offices, Open-end de la American Stock Exchange avec le ticker XTL. Le dernier cours de clôture d'SPDR S&P Telecom ETF était de US$109,92. Au cours de la dernière année, les actions de SPDR S&P Telecom ETF ont été négociées dans une fourchette de prix de US$ 67,08 à US$ 111,2338.

SPDR S&P Telecom ETF compte actuellement 775 000 actions en circulation. La capitalisation boursière d'SPDR S&P Telecom ETF est de US$85,19 million. SPDR S&P Telecom ETF a un ratio cours/bénéfice (ratio PE) de -2493.39.

XTL Dernières nouvelles

XTL Biopharmaceuticals Provides Update on Potential Strategic Alternatives

VALLEY COTTAGE, N.Y., Jan. 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLBNASDAQ:TASE:NASDAQ:XTL) today announced an update to its December 8, 2008 press release regarding...

XTLbio Announces Grant of hMAb Patent

XTLbio Announces Grant of Human Monoclonal Antibody Patent Patent Covers Antibodies Directed Against Hepatitis B Virus Surface Antigen Rehovot, Israel 26 January 2004 - XTL Biopharmaceuticals...

XTLbio appoints Stockbroker and Financial Adviser

XTLbio appoints Stockbroker and Financial Adviser Rehovot, 20 January 2004 - The Board of XTL Biopharmaceuticals Ltd ("XTLbio" or the "Company") is pleased to announce the appointment of Code...

XTLbio announces appointment of Non-Executive Director

XTLbio announces appointment of Non-Executive Director Rehovot, 12 January 2004 - XTL Biopharmaceuticals Ltd. (LSE:XTL) is pleased to announce the appointment of Peter Stalker, III, as a...

Business Update

RNS Number:2908T XTL Biopharmaceuticals Limited 16 December 2003 XTLbio R&D and Business Development Update Rehovot, Israel, 16 December 2003 - XTL Biopharmaceuticals Ltd (XTLbio) today...

XTLbio R&D and Business Development Update

XTLbio R&D and Business Development Update Rehovot, Israel, 16 December 2003 - XTL Biopharmaceuticals Ltd (XTLbio) today announces an update on recent clinical progress and corporate developments...

XTLbio Highlights Presence at The Liver Meeting

XTLbio Highlights Presence at The Liver Meeting HepeX Programs at 54th Annual AASLD include Poster Presentations, Oral Presentation and Exhibitors Booth Rehovot, Israel, 28 October 2003: XTL...

Directorate Change

XTLbio announces appointment of Non-Executive Director Rehovot, Israel, 20 October 2003: XTL Biopharmaceuticals Ltd. (LSE:XTL) is pleased to announce the appointment of Dr. Hadar Ron as a...

Holding(s) in Company

NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company XTL Biopharmaceuticals Limited 2) Name of shareholder having a major interest Perpetual Income & Growth Investment Trust plc 3) Please...

XTLbio ACQUIRES RIGHTS FROM STANFORD UNIVERSITY

XTLbio ACQUIRES BROAD RIGHTS FROM STANFORD UNIVERSITY TO ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS (HCV) Exclusive license enhances XTLbio's HepeX-C program in clinical development Rehovot...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
14.774.55326460481104.76111.2338103.799281108.60341968SP
46.776.58816660179102.76111.2338100.8716691106.35387436SP
1217.5919.132042636591.94111.233891.3814360102.04091021SP
2634.9246.803377563374.61111.233873.65291140894.81442059SP
5239.8157.09982788369.72111.233867.08779789.78942234SP
15610.4210.513570779999.11111.233864.09707384.23145347SP
26040.3958.417703210969.14111.233848.47930085.81200144SP
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées